RELX Plc (RELX)
RELX Plc operates in the Specialty Business Services industry of the Industrials sector, headquartered in London, GL, GB. The stock last traded at $33.45, up 0.13% on the session, giving a market capitalisation of $58.41B. On trailing twelve-month figures it carries a trailing P/E of 19.68, a net margin of 23.3%. Its beta of 0.26 implies it has historically moved less than the broad market.
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
RELX Plc is most often compared with the following Industrials names: